Northrop Grumman: Mixed Analyst Sentiment
Citi Lowers Northrop Grumman Price Target, Keeps Buy Rating Amid Mixed Analyst Views
Key Points
MarketBeat shows a distribution of analyst ratings for Northrop Grumman: 2 Strong Buy, 10 Buy, and 9 Hold.
MarketBeat's consensus target sits at $698.37, indicating a target in the high-600s.
In the latest quarter, Northrop Grumman posted a net margin of 10.80% and a return on equity of 24.72%.
Citigroup lowered Northrop Grumman's price target to $587 from $628 but kept a Buy rating, noting updated estimates ahead of Q2 and suggesting aerospace could see bigger beats while defense may be more muted due to compressed multiples.
Northrop Grumman reported its latest quarterly results on April 21, the date of the release cited in coverage.
Citigroup cut its price target on Northrop Grumman (NYSE: NOC) to $587 from $628 on July 1, 2026, while keeping a Buy rating, according to TipRanks. Analyst John Godyn signaled a cautious near-term view, noting that defense stocks face "compressed multiples" even as aerospace names may see big earnings beats.
The cut is the second from Citi in six weeks. Godyn had already trimmed the target from $742 to $628 on May 18. Despite that, he sees Northrop as a Buy — just with less room to run in the short term, Benzinga reported.
Citi Shifts to Defense-First Thesis Amid Valuation Pressure
Godyn's July 1 note laid out a tactical shift. Citi now favors what it calls a "Defense Now" approach — meaning defense primes like Northrop may benefit as commercial aerospace valuations peak and capital rotates back into the sector. Godyn said aerospace could post "big beats" this cycle, but defense names are more likely to see "multiples drive outsized reactions" as growth accelerates into 2027, Investing.com reported.
The core concern is not demand. Northrop holds a record $96 billion backlog, according to MarketBeat. The issue is the heavy spending required to scale up programs like the B-21 Raider stealth bomber and the Sentinel ICBM. Capital expenditures are expected to hit $1.85 billion in 2026 alone, which squeezes near-term free cash flow.
Q1 Beat Did Not Stop the Stock From Selling Off
Northrop reported Q1 2026 results on April 21. The company earned $6.14 per diluted share on $9.9 billion in revenue, beating Wall Street estimates of $6.06 EPS and $9.8 billion in sales. Net margin came in at 10.80% and return on equity hit 24.72%, according to MarketBeat.
Despite the beat, the stock sold off sharply. Investors focused on a charge in the Space Systems segment and concerns about cash burn. CEO Kathy Warden called the results a reflection of "the strength of our portfolio," pointing to the B-21 and Sentinel programs as long-term pillars, GuruFocus reported. CFO John Greene reaffirmed full-year 2026 sales guidance of $43.5 billion to $44 billion.
Street Is Split: Targets Range From $580 to $815
Analyst views on Northrop span a wide range. BTIG's Andre Madrid holds the highest target on the street at $815, arguing the B-21 and space-based interceptors are deeply undervalued long-term assets. UBS cut its target from $745 to $666 on June 29 but kept a Buy. Jefferies analyst Sheila Kahyaoglu is the most cautious, holding a $580 target and a Hold rating, citing margin pressure in the Defense Systems segment, StreetInsider reported.
The consensus sits at a Moderate Buy, with 2 Strong Buy, 10 Buy, and 9 Hold ratings tracked by MarketBeat. The average price target is $698.37, well above Citi's $587 but below BTIG's $815. Weiss Ratings recently moved to Hold, saying the stock looks fairly valued near its current trading range.
Dividend Hike and Q2 Results Could Be the Next Catalysts
Northrop recently raised its annual dividend by 7%, backed by projected free cash flow of $3.1 billion to $3.5 billion. The company also committed $2.5 billion to new facilities and added 2 million square feet of manufacturing space, signaling confidence in long-term demand for its aerospace and defense programs, according to GuruFocus.
The next major test comes July 21, 2026, when Northrop reports Q2 results. Citi's $587 target acts as a conservative floor in an uncertain market. If Northrop hits its margin targets this quarter, analysts at BTIG and Morgan Stanley believe the stock could move back toward the $700–$800 range, Investing.com noted.
Sentiment
Mostly PositivePublishers
10
Articles
6
Reach
16
